메뉴 건너뛰기




Volumn 97, Issue 6, 2012, Pages 805-817

Acute myeloid leukemia developing in patients with autoimmune diseases

Author keywords

Autoimmune disease; Inflammatory bowel disease; Multiple sclerosis; Rheumatoid arthritis; Secondary leukemia; Systemic lupus erythematosus

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; BETA INTERFERON; BORTEZOMIB; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ETANERCEPT; ETOPOSIDE; GLATIRAMER; HYDROXYCHLOROQUINE; HYDROXYUREA; IDARUBICIN; IMATINIB; INFLIXIMAB; LEFLUNOMIDE; MERCAPTOPURINE; METHOTREXATE; MINOCYCLINE; MITOXANTRONE; PENICILLAMINE; SALAZOSULFAPYRIDINE; STEROID; TIOGUANINE; TUMOR NECROSIS FACTOR INHIBITOR; VINCRISTINE;

EID: 84862127535     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.056283     Document Type: Review
Times cited : (62)

References (176)
  • 1
    • 0036237268 scopus 로고    scopus 로고
    • Therapy of secondary leukemia
    • Rowe JM. Therapy of secondary leukemia. Leukemia. 2002;16(4):748-50.
    • (2002) Leukemia. , vol.16 , Issue.4 , pp. 748-750
    • Rowe, J.M.1
  • 2
    • 70349256226 scopus 로고    scopus 로고
    • The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes
    • Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114(5): 937-51.
    • (2009) Blood. , vol.114 , Issue.5 , pp. 937-951
    • Vardiman, J.W.1    Thiele, J.2    Arber, D.A.3    Brunning, R.D.4    Borowitz, M.J.5    Porwit, A.6
  • 3
    • 48749090278 scopus 로고    scopus 로고
    • Therapy-related myeloid leukemia
    • Godley LA, Larson RA. Therapy-related myeloid leukemia. Semin Oncol. 2008;35 (4):418-29.
    • (2008) Semin Oncol. , vol.35 , Issue.4 , pp. 418-429
    • Godley, L.A.1    Larson, R.A.2
  • 4
    • 79951825094 scopus 로고    scopus 로고
    • The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML
    • Kayser S, Dohner K, Krauter J, Kohne CH, Horst HA, Held G, et al. The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. Blood. 117(7):2137-45.
    • Blood. , vol.117 , Issue.7 , pp. 2137-2145
    • Kayser, S.1    Dohner, K.2    Krauter, J.3    Kohne, C.H.4    Horst, H.A.5    Held, G.6
  • 5
    • 33748750051 scopus 로고    scopus 로고
    • Cancer immunosuppression and autoimmune disease: Beyond immunosuppressive networks for tumour immunity
    • Kim R, Emi M, Tanabe K. Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity. Immunology. 2006;119 (2):254-64.
    • (2006) Immunology. , vol.119 , Issue.2 , pp. 254-264
    • Kim, R.1    Emi, M.2    Tanabe, K.3
  • 6
    • 3242756741 scopus 로고    scopus 로고
    • Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation
    • Offman J, Opelz G, Doehler B, Cummins D, Halil O, Banner NR, et al. Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation. Blood. 2004;104 (3):822-8.
    • (2004) Blood. , vol.104 , Issue.3 , pp. 822-828
    • Offman, J.1    Opelz, G.2    Doehler, B.3    Cummins, D.4    Halil, O.5    Banner, N.R.6
  • 7
    • 77956249684 scopus 로고    scopus 로고
    • Therapy-related myeloid neoplasms in patients with acute promyelocytic leukemia treated with all-trans-retinoic Acid and anthracycline-based chemotherapy
    • Montesinos P, Gonzalez JD, Gonzalez J, Rayon C, de Lisa E, Amigo ML, et al. Therapy-related myeloid neoplasms in patients with acute promyelocytic leukemia treated with all-trans-retinoic Acid and anthracycline-based chemotherapy. J Clin Oncol. 2010;28(24):3872-9.
    • (2010) J Clin Oncol. , vol.28 , Issue.24 , pp. 3872-3879
    • Montesinos, P.1    Gonzalez, J.D.2    Gonzalez, J.3    Rayon, C.4    de Lisa, E.5    Amigo, M.L.6
  • 8
    • 0141819043 scopus 로고    scopus 로고
    • The epidemiology of autoimmune diseases
    • Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev. 2003;2(3):119-25.
    • (2003) Autoimmun Rev. , vol.2 , Issue.3 , pp. 119-125
    • Cooper, G.S.1    Stroehla, B.C.2
  • 9
    • 71649086164 scopus 로고    scopus 로고
    • Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases
    • Cooper GS, Bynum ML, Somers EC. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun. 2009;33(3-4):197-207.
    • (2009) J Autoimmun. , vol.33 , Issue.3-4 , pp. 197-207
    • Cooper, G.S.1    Bynum, M.L.2    Somers, E.C.3
  • 10
    • 0037006252 scopus 로고    scopus 로고
    • Relative importance of genetic effects in rheumatoid arthritis: Historical cohort study of Danish nationwide twin population
    • Svendsen AJ, Holm NV, Kyvik K, Petersen PH, Junker P. Relative importance of genetic effects in rheumatoid arthritis: historical cohort study of Danish nationwide twin population. BMJ. 2002;324(7332):264-6.
    • (2002) BMJ. , vol.324 , Issue.7332 , pp. 264-266
    • Svendsen, A.J.1    Holm, N.V.2    Kyvik, K.3    Petersen, P.H.4    Junker, P.5
  • 11
    • 79551512143 scopus 로고    scopus 로고
    • Insecticide use and risk of rheumatoid arthritis and systemic lupus erythematosus in the Women's Health Initiative Observational Study
    • Parks CG, Walitt BT, Pettinger M, Chen JC, de Roos AJ, Hunt J, et al. Insecticide use and risk of rheumatoid arthritis and systemic lupus erythematosus in the Women's Health Initiative Observational Study. Arthritis Care Res (Hoboken). 2011;63(2):184-94.
    • (2011) Arthritis Care Res (Hoboken). , vol.63 , Issue.2 , pp. 184-194
    • Parks, C.G.1    Walitt, B.T.2    Pettinger, M.3    Chen, J.C.4    de Roos, A.J.5    Hunt, J.6
  • 12
    • 33750301846 scopus 로고    scopus 로고
    • Occupational and environmental associations with antinuclear antibodies in a general population sample
    • Cooper GS, Parks CG, Schur PS, Fraser PA. Occupational and environmental associations with antinuclear antibodies in a general population sample. J Toxicol Environ Health A. 2006;69(23):2063-9.
    • (2006) J Toxicol Environ Health A. , vol.69 , Issue.23 , pp. 2063-2069
    • Cooper, G.S.1    Parks, C.G.2    Schur, P.S.3    Fraser, P.A.4
  • 13
    • 16544385459 scopus 로고    scopus 로고
    • Occupational and environmental exposures as risk factors for systemic lupus erythematosus
    • Cooper GS, Parks CG. Occupational and environmental exposures as risk factors for systemic lupus erythematosus. Curr Rheumatol Rep. 2004;6(5):367-74.
    • (2004) Curr Rheumatol Rep. , vol.6 , Issue.5 , pp. 367-374
    • Cooper, G.S.1    Parks, C.G.2
  • 16
    • 0142061467 scopus 로고    scopus 로고
    • Epidemiology of multiple sclerosis: Environmental factors versus genetic factors
    • Kira J. [Epidemiology of multiple sclerosis: environmental factors versus genetic factors]. Nippon Rinsho. 2003;61(8):1300-10.
    • (2003) Nippon Rinsho. , vol.61 , Issue.8 , pp. 1300-1310
    • Kira, J.1
  • 18
    • 38449084395 scopus 로고    scopus 로고
    • Genetic analysis of systemic autoimmunity
    • discussion 120-8, 208-9
    • Vinuesa CG, Cook MC. Genetic analysis of systemic autoimmunity. Novartis Found Symp. 2007;281:103-20; discussion 120-8, 208-9.
    • (2007) Novartis Found Symp. , vol.281 , pp. 103-120
    • Vinuesa, C.G.1    Cook, M.C.2
  • 20
    • 45349090538 scopus 로고    scopus 로고
    • American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
    • Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 2008;59(6):762-84.
    • (2008) Arthritis Rheum. , vol.59 , Issue.6 , pp. 762-784
    • Saag, K.G.1    Teng, G.G.2    Patkar, N.M.3    Anuntiyo, J.4    Finney, C.5    Curtis, J.R.6
  • 22
    • 79960709287 scopus 로고    scopus 로고
    • Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes
    • Kristinsson SY, Bjorkholm M, Hultcrantz M, Derolf AR, Landgren O, Goldin LR. Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J Clin Oncol. 29(21):2897-903.
    • J Clin Oncol. , vol.29 , Issue.21 , pp. 2897-2903
    • Kristinsson, S.Y.1    Bjorkholm, M.2    Hultcrantz, M.3    Derolf, A.R.4    Landgren, O.5    Goldin, L.R.6
  • 23
    • 0017644690 scopus 로고
    • Acute leukemia after azathioprine treatment of connective tissue disease
    • Alexson E, Brandt KD. Acute leukemia after azathioprine treatment of connective tissue disease. Am J Med Sci. 1977;273 (3):335-40.
    • (1977) Am J Med Sci. , vol.273 , Issue.3 , pp. 335-340
    • Alexson, E.1    Brandt, K.D.2
  • 24
    • 0032527868 scopus 로고    scopus 로고
    • Acute myeloid leukemia after azathioprine treatment for autoimmune diseases: Association with-7/7q
    • Kwong YL, Au WY, Liang RH. Acute myeloid leukemia after azathioprine treatment for autoimmune diseases: association with-7/7q. Cancer Genet Cytogenet. 1998;104(2):94-7.
    • (1998) Cancer Genet Cytogenet. , vol.104 , Issue.2 , pp. 94-97
    • Kwong, Y.L.1    Au, W.Y.2    Liang, R.H.3
  • 25
    • 0036693720 scopus 로고    scopus 로고
    • Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: A coincidental coexistence or a causal relationship
    • Espinosa G, Font J, Munoz-Rodriguez FJ, Cervera R, Ingelmo M. Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship? Clin Rheumatol. 2002;21(4):309-13.
    • (2002) Clin Rheumatol. , vol.21 , Issue.4 , pp. 309-313
    • Espinosa, G.1    Font, J.2    Munoz-Rodriguez, F.J.3    Cervera, R.4    Ingelmo, M.5
  • 26
    • 0345731425 scopus 로고    scopus 로고
    • Myelodysplastic syndrome associated with low-dose methotrexate in rheumatoid arthritis
    • Okamoto H, Teramura M, Kamatani N. Myelodysplastic syndrome associated with low-dose methotrexate in rheumatoid arthritis. Ann Pharmacother. 2004;38(1): 172-3.
    • (2004) Ann Pharmacother. , vol.38 , Issue.1 , pp. 172-173
    • Okamoto, H.1    Teramura, M.2    Kamatani, N.3
  • 27
    • 20044387442 scopus 로고    scopus 로고
    • Acute erythroleukemia in a rheumatoid arthritis patient during low-dose methotrexate therapy
    • Choi BR, Ahn MJ, Lee WS, Kim TH, Bae SC, Jun JB. Acute erythroleukemia in a rheumatoid arthritis patient during low-dose methotrexate therapy. Rheumatol Int. 2005;25(4):311-3.
    • (2005) Rheumatol Int. , vol.25 , Issue.4 , pp. 311-313
    • Choi, B.R.1    Ahn, M.J.2    Lee, W.S.3    Kim, T.H.4    Bae, S.C.5    Jun, J.B.6
  • 28
    • 13944276418 scopus 로고    scopus 로고
    • Myelodysplasia and acute myeloid leukaemia in a case of rheumatoid arthritis with secondary amyloidosis treated with chlorambucil
    • Balakrishnan C, Pathan E, Khodaiji S, Dasgupta A, Mangat G, Joshi VR. Myelodysplasia and acute myeloid leukaemia in a case of rheumatoid arthritis with secondary amyloidosis treated with chlorambucil. J Assoc Physicians India. 2004;52:423-5.
    • (2004) J Assoc Physicians India. , vol.52 , pp. 423-425
    • Balakrishnan, C.1    Pathan, E.2    Khodaiji, S.3    Dasgupta, A.4    Mangat, G.5    Joshi, V.R.6
  • 30
    • 0029828620 scopus 로고    scopus 로고
    • Myelodysplastic syndromes and acute myeloid leukemia in connective tissue disease after single-agent chemotherapy
    • Rosenthal NS, Farhi DC. Myelodysplastic syndromes and acute myeloid leukemia in connective tissue disease after single-agent chemotherapy. Am J Clin Pathol. 1996;106 (5):676-9.
    • (1996) Am J Clin Pathol. , vol.106 , Issue.5 , pp. 676-679
    • Rosenthal, N.S.1    Farhi, D.C.2
  • 31
    • 0018110856 scopus 로고
    • Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis
    • Isomaki HA, Hakulinen T, Joutsenlahti U. Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis. 1978;31(11):691-6.
    • (1978) J Chronic Dis. , vol.31 , Issue.11 , pp. 691-696
    • Isomaki, H.A.1    Hakulinen, T.2    Joutsenlahti, U.3
  • 34
    • 0021924601 scopus 로고
    • Cancer and rheumatoid arthritis: Epidemiologic considerations
    • Prior P. Cancer and rheumatoid arthritis: epidemiologic considerations. Am J Med. 1985;78(1A):15-21.
    • (1985) Am J Med. , vol.78 , Issue.1 A , pp. 15-21
    • Prior, P.1
  • 35
    • 0030848726 scopus 로고    scopus 로고
    • Rheumatoid arthritis and the risk of malignancy
    • Cibere J, Sibley J, Haga M. Rheumatoid arthritis and the risk of malignancy. Arthritis Rheum. 1997;40(9):1580-6.
    • (1997) Arthritis Rheum. , vol.40 , Issue.9 , pp. 1580-1586
    • Cibere, J.1    Sibley, J.2    Haga, M.3
  • 36
    • 27744520447 scopus 로고    scopus 로고
    • Haematopoietic malignancies in rheumatoid arthritis: Lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
    • Askling J, Fored CM, Baecklund E, Brandt L, Backlin C, Ekbom A, et al. Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis. 2005;64(10):1414-20.
    • (2005) Ann Rheum Dis. , vol.64 , Issue.10 , pp. 1414-1420
    • Askling, J.1    Fored, C.M.2    Baecklund, E.3    Brandt, L.4    Backlin, C.5    Ekbom, A.6
  • 37
    • 68849126243 scopus 로고    scopus 로고
    • Risk of cancer among rheumatoid arthritis patients in California
    • Parikh-Patel A, White RH, Allen M, Cress R. Risk of cancer among rheumatoid arthritis patients in California. Cancer Causes Control. 2009;20(6):1001-10.
    • (2009) Cancer Causes Control. , vol.20 , Issue.6 , pp. 1001-1010
    • Parikh-Patel, A.1    White, R.H.2    Allen, M.3    Cress, R.4
  • 39
    • 40449106365 scopus 로고    scopus 로고
    • Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis
    • Bernatsky S, Clarke AE, Suissa S. Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis. Arch Intern Med. 2008;168(4):378-81.
    • (2008) Arch Intern Med. , vol.168 , Issue.4 , pp. 378-381
    • Bernatsky, S.1    Clarke, A.E.2    Suissa, S.3
  • 40
    • 66149084485 scopus 로고    scopus 로고
    • Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: Relative risks and time trends in the Swedish Biologics Register
    • Askling J, Baecklund E, Granath F, Geborek P, Fored M, Backlin C, et al. Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register. Ann Rheum Dis. 2009;68(5):648-53.
    • (2009) Ann Rheum Dis. , vol.68 , Issue.5 , pp. 648-653
    • Askling, J.1    Baecklund, E.2    Granath, F.3    Geborek, P.4    Fored, M.5    Backlin, C.6
  • 41
    • 17644374819 scopus 로고    scopus 로고
    • Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas
    • Geborek P, Bladstrom A, Turesson C, Gulfe A, Petersson IF, Saxne T, et al. Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas. Ann Rheum Dis. 2005;64(5):699-703.
    • (2005) Ann Rheum Dis. , vol.64 , Issue.5 , pp. 699-703
    • Geborek, P.1    Bladstrom, A.2    Turesson, C.3    Gulfe, A.4    Petersson, I.F.5    Saxne, T.6
  • 42
    • 33749346419 scopus 로고    scopus 로고
    • Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis
    • Setoguchi S, Solomon DH, Weinblatt ME, Katz JN, Avorn J, Glynn RJ, et al. Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum. 2006;54(9):2757-64.
    • (2006) Arthritis Rheum. , vol.54 , Issue.9 , pp. 2757-2764
    • Setoguchi, S.1    Solomon, D.H.2    Weinblatt, M.E.3    Katz, J.N.4    Avorn, J.5    Glynn, R.J.6
  • 43
    • 0032931201 scopus 로고    scopus 로고
    • Efficacy and safety of a combination therapy of methotrexate, chloroquine and cyclophosphamide in patients with refractory rheumatoid arthritis: Results of an observational study with matched-pair analysis
    • Keyszer G, Keysser C, Keysser M. Efficacy and safety of a combination therapy of methotrexate, chloroquine and cyclophosphamide in patients with refractory rheumatoid arthritis: results of an observational study with matched-pair analysis. Clin Rheumatol. 1999;18(2):145-51.
    • (1999) Clin Rheumatol. , vol.18 , Issue.2 , pp. 145-151
    • Keyszer, G.1    Keysser, C.2    Keysser, M.3
  • 44
    • 0141564911 scopus 로고    scopus 로고
    • Rate of death due to leukemia/lymphoma in patients with rheumatoid arthritis
    • Wolfe F, Fries JF. Rate of death due to leukemia/lymphoma in patients with rheumatoid arthritis. Arthritis Rheum. 2003;48(9):2694-5.
    • (2003) Arthritis Rheum. , vol.48 , Issue.9 , pp. 2694-2695
    • Wolfe, F.1    Fries, J.F.2
  • 45
    • 44349093644 scopus 로고    scopus 로고
    • Cancer in rheumatoid arthritis: Occurrence, mortality, and associated factors in a South European population
    • Abasolo L, Judez E, Descalzo MA, Gonzalez-Alvaro I, Jover JA, Carmona L. Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a South European population. Semin Arthritis Rheum. 2008;37(6):388-97.
    • (2008) Semin Arthritis Rheum. , vol.37 , Issue.6 , pp. 388-397
    • Abasolo, L.1    Judez, E.2    Descalzo, M.A.3    Gonzalez-Alvaro, I.4    Jover, J.A.5    Carmona, L.6
  • 46
    • 0347991877 scopus 로고    scopus 로고
    • The safety profile of infliximab in patients with Crohn's disease: The Mayo clinic experience in 500 patients
    • Colombel JF, Loftus EV Jr, Tremaine WJ, Egan LJ, Harmsen WS, Schleck CD, et al. The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. Gastroenterology. 2004;126(1):19-31.
    • (2004) Gastroenterology. , vol.126 , Issue.1 , pp. 19-31
    • Colombel, J.F.1    Loftus Jr., E.V.2    Tremaine, W.J.3    Egan, L.J.4    Harmsen, W.S.5    Schleck, C.D.6
  • 47
    • 69749083197 scopus 로고    scopus 로고
    • Emerging issues in ulcerative colitis and ulcerative proctitis: Individualizing treatment to maximize outcomes
    • Hanauer SB, Present DH, Rubin DT. Emerging issues in ulcerative colitis and ulcerative proctitis: individualizing treatment to maximize outcomes. Gastroenterol Hepatol (NY). 2009;5(6 Suppl):4-16.
    • (2009) Gastroenterol Hepatol (NY). , vol.5 , Issue.6 SUPPL. , pp. 4-16
    • Hanauer, S.B.1    Present, D.H.2    Rubin, D.T.3
  • 48
    • 2442563304 scopus 로고    scopus 로고
    • Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences
    • Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004;126(6):1504-17.
    • (2004) Gastroenterology. , vol.126 , Issue.6 , pp. 1504-1517
    • Loftus Jr., E.V.1
  • 49
    • 80054021388 scopus 로고    scopus 로고
    • Current and emerging drugs for the treatment of inflammatory bowel disease
    • Triantafillidis JK, Merikas E, Georgopoulos F. Current and emerging drugs for the treatment of inflammatory bowel disease. Drug Des Devel Ther. 2011;5:185-210.
    • (2011) Drug Des Devel Ther. , vol.5 , pp. 185-210
    • Triantafillidis, J.K.1    Merikas, E.2    Georgopoulos, F.3
  • 50
    • 0019171681 scopus 로고
    • Acute myelogenous leukemia in patients with ulcerative colitis
    • Fabry TL, Sachar DB, Janowitz HD. Acute myelogenous leukemia in patients with ulcerative colitis. J Clin Gastroenterol. 1980; 2(3):225-7.
    • (1980) J Clin Gastroenterol. , vol.2 , Issue.3 , pp. 225-227
    • Fabry, T.L.1    Sachar, D.B.2    Janowitz, H.D.3
  • 51
    • 0025911925 scopus 로고
    • Acute promyelocytic leukemia in Crohn's disease. Case report and review of the literature
    • Orii S, Sugai T, Nakano O, Yoshinari H, Sato S. Acute promyelocytic leukemia in Crohn's disease. Case report and review of the literature. J Clin Gastroenterol. 1991;13(3):325-7.
    • (1991) J Clin Gastroenterol. , vol.13 , Issue.3 , pp. 325-327
    • Orii, S.1    Sugai, T.2    Nakano, O.3    Yoshinari, H.4    Sato, S.5
  • 52
    • 0029152855 scopus 로고
    • De novo acute myeloid leukemia in patients with Crohn's disease
    • Dombret H, Marolleau JP. De novo acute myeloid leukemia in patients with Crohn's disease. Nouv Rev Fr Hematol. 1995;37 (3):193-6.
    • (1995) Nouv Rev Fr Hematol. , vol.37 , Issue.3 , pp. 193-196
    • Dombret, H.1    Marolleau, J.P.2
  • 54
    • 0021333214 scopus 로고
    • Inflammatory bowel disease and leukemia
    • Cohn EM, Pearlstine B. Inflammatory bowel disease and leukemia. J Clin Gastroenterol. 1984;6(1):33-5.
    • (1984) J Clin Gastroenterol. , vol.6 , Issue.1 , pp. 33-35
    • Cohn, E.M.1    Pearlstine, B.2
  • 55
    • 0025598283 scopus 로고
    • Development of acute myelocytic leukemia in patients with Crohn's disease
    • Halme L, von Knorring J, Elonen E. Development of acute myelocytic leukemia in patients with Crohn's disease. Dig Dis Sci. 1990;35(12):1553-6.
    • (1990) Dig Dis Sci. , vol.35 , Issue.12 , pp. 1553-1556
    • Halme, L.1    von Knorring, J.2    Elonen, E.3
  • 56
    • 0028948834 scopus 로고
    • Crohn disease and the myelodysplastic syndrome
    • Boberg KM, Brinch L, Vatn M. Crohn disease and the myelodysplastic syndrome. Ann Intern Med. 1995;122(5):395.
    • (1995) Ann Intern Med. , vol.122 , Issue.5 , pp. 395
    • Boberg, K.M.1    Brinch, L.2    Vatn, M.3
  • 57
    • 33947698296 scopus 로고    scopus 로고
    • Hematological malignancies in chronic inflammatory bowel diseases: Report of five cases and review of the literature
    • Crispino P, Pica R, Angelucci E, Consolazio A, Rivera M, Cassieri C, et al. Hematological malignancies in chronic inflammatory bowel diseases: report of five cases and review of the literature. Int J Colorectal Dis. 2007;22(5):553-8.
    • (2007) Int J Colorectal Dis. , vol.22 , Issue.5 , pp. 553-558
    • Crispino, P.1    Pica, R.2    Angelucci, E.3    Consolazio, A.4    Rivera, M.5    Cassieri, C.6
  • 58
    • 77956269303 scopus 로고    scopus 로고
    • Treatmentassociated acute myeloid leukemia in a patient with Crohn's disease on 6-mercaptopurine
    • Das KK, Nishino HT, Chan AT. Treatmentassociated acute myeloid leukemia in a patient with Crohn's disease on 6-mercaptopurine. Inflamm Bowel Dis. 2010;16(9): 1454-6.
    • (2010) Inflamm Bowel Dis. , vol.16 , Issue.9 , pp. 1454-1456
    • Das, K.K.1    Nishino, H.T.2    Chan, A.T.3
  • 59
    • 77957568167 scopus 로고    scopus 로고
    • Acute myeloid leukemia after one month of azathioprine therapy in a Crohn's disease patient
    • Kallel L, Naijaa N, Fekih M, Frikha I, Boubaker J, Bellaaj H, et al. Acute myeloid leukemia after one month of azathioprine therapy in a Crohn's disease patient. J Clin Gastroenterol. 2010;44(9):660.
    • (2010) J Clin Gastroenterol. , vol.44 , Issue.9 , pp. 660
    • Kallel, L.1    Naijaa, N.2    Fekih, M.3    Frikha, I.4    Boubaker, J.5    Bellaaj, H.6
  • 61
    • 0022543170 scopus 로고
    • Inflammatory bowel disease and leukemia. A report of seven cases of leukemia in ulcerative colitis and Crohn's disease and review of the literature
    • Mir Madjlessi SH, Farmer RG, Weick JK. Inflammatory bowel disease and leukemia. A report of seven cases of leukemia in ulcerative colitis and Crohn's disease and review of the literature. Dig Dis Sci. 1986;31(10): 1025-31.
    • (1986) Dig Dis Sci. , vol.31 , Issue.10 , pp. 1025-1031
    • Mir Madjlessi, S.H.1    Farmer, R.G.2    Weick, J.K.3
  • 63
    • 0035865012 scopus 로고    scopus 로고
    • Cancer risk in patients with inflammatory bowel disease: A populationbased study
    • Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: a populationbased study. Cancer. 2001;91(4):854-62.
    • (2001) Cancer. , vol.91 , Issue.4 , pp. 854-862
    • Bernstein, C.N.1    Blanchard, J.F.2    Kliewer, E.3    Wajda, A.4
  • 64
    • 17644386242 scopus 로고    scopus 로고
    • Risk of haematopoietic cancer in patients with inflammatory bowel disease
    • Askling J, Brandt L, Lapidus A, Karlen P, Bjorkholm M, Lofberg R, et al. Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut. 2005;54 (5):617-22.
    • (2005) Gut. , vol.54 , Issue.5 , pp. 617-622
    • Askling, J.1    Brandt, L.2    Lapidus, A.3    Karlen, P.4    Bjorkholm, M.5    Lofberg, R.6
  • 65
  • 66
    • 33845482745 scopus 로고    scopus 로고
    • A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
    • Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, et al. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Health Technol Assess. 2006;10(42): iii-iv, xixiii, 1-229.
    • (2006) Health Technol Assess. , vol.10 , Issue.42
    • Chen, Y.F.1    Jobanputra, P.2    Barton, P.3    Jowett, S.4    Bryan, S.5    Clark, W.6
  • 68
    • 0022508976 scopus 로고
    • Colorectal and extracolonic malignancy in ulcerative colitis
    • Mir-Madjlessi SH, Farmer RG, Easley KA, Beck GJ. Colorectal and extracolonic malignancy in ulcerative colitis. Cancer. 1986;58 (7):1569-74.
    • (1986) Cancer. , vol.58 , Issue.7 , pp. 1569-1574
    • Mir-Madjlessi, S.H.1    Farmer, R.G.2    Easley, K.A.3    Beck, G.J.4
  • 69
    • 17944382692 scopus 로고    scopus 로고
    • Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide study
    • Viscido A, Bagnardi V, Sturniolo GC, Annese V, Frieri G, D'Arienzo A, et al. Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide study. Dig Liver Dis. 2001;33(8):686-92.
    • (2001) Dig Liver Dis. , vol.33 , Issue.8 , pp. 686-692
    • Viscido, A.1    Bagnardi, V.2    Sturniolo, G.C.3    Annese, V.4    Frieri, G.5    D'Arienzo, A.6
  • 70
    • 0031946235 scopus 로고    scopus 로고
    • General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: The Florence Study
    • Palli D, Trallori G, Saieva C, Tarantino O, Edili E, D'Albasio G, et al. General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence Study. Gut. 1998;42(2): 175-9.
    • (1998) Gut. , vol.42 , Issue.2 , pp. 175-179
    • Palli, D.1    Trallori, G.2    Saieva, C.3    Tarantino, O.4    Edili, E.5    D'Albasio, G.6
  • 71
    • 1342331541 scopus 로고    scopus 로고
    • Intestinal and extra-intestinal cancer in Crohn's disease: Follow-up of a population-based cohort in Copenhagen County, Denmark
    • Jess T, Winther KV, Munkholm P, Langholz E, Binder V. Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Aliment Pharmacol Ther. 2004;19(3):287-93.
    • (2004) Aliment Pharmacol Ther. , vol.19 , Issue.3 , pp. 287-293
    • Jess, T.1    Winther, K.V.2    Munkholm, P.3    Langholz, E.4    Binder, V.5
  • 72
    • 4344640131 scopus 로고    scopus 로고
    • Clinical management of multiple sclerosis: The treatment paradigm and issues of patient management
    • Stuart WH. Clinical management of multiple sclerosis: the treatment paradigm and issues of patient management. J Manag Care Pharm. 2004;10(3 Suppl B):S19-25.
    • (2004) J Manag Care Pharm. , vol.10 , Issue.3 SUPPL. B
    • Stuart, W.H.1
  • 74
    • 0345305703 scopus 로고    scopus 로고
    • The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
    • Goodin DS, Arnason BG, Coyle PK, Frohman EM, Paty DW. The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2003;61(10):1332-8.
    • (2003) Neurology. , vol.61 , Issue.10 , pp. 1332-1338
    • Goodin, D.S.1    Arnason, B.G.2    Coyle, P.K.3    Frohman, E.M.4    Paty, D.W.5
  • 75
    • 79953199080 scopus 로고    scopus 로고
    • Risk of acute promyelocytic leukemia in multiple sclerosis: Coding variants of DNA repair genes
    • Hasan SK, Buttari F, Ottone T, Voso MT, Hohaus S, Marasco E, et al. Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes. Neurology. 76(12):1059-65.
    • Neurology , vol.76 , Issue.12 , pp. 1059-1065
    • Hasan, S.K.1    Buttari, F.2    Ottone, T.3    Voso, M.T.4    Hohaus, S.5    Marasco, E.6
  • 76
    • 54049153246 scopus 로고    scopus 로고
    • Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis
    • Hasan SK, Mays AN, Ottone T, Ledda A, La Nasa G, Cattaneo C, et al. Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis. Blood. 2008;112(8):3383-90.
    • (2008) Blood. , vol.112 , Issue.8 , pp. 3383-3390
    • Hasan, S.K.1    Mays, A.N.2    Ottone, T.3    Ledda, A.4    la Nasa, G.5    Cattaneo, C.6
  • 77
    • 0017140129 scopus 로고
    • Acute myeloblastic leukemia after immunodepressive therapy for primary nonmalignant disease
    • Tchernia G, Mielot F, Subtil E, Parmentier C. Acute myeloblastic leukemia after immunodepressive therapy for primary nonmalignant disease. Nouv Rev Fr Hematol Blood Cells. 1976;17(1-2):67-80.
    • (1976) Nouv Rev Fr Hematol Blood Cells. , vol.17 , Issue.1-2 , pp. 67-80
    • Tchernia, G.1    Mielot, F.2    Subtil, E.3    Parmentier, C.4
  • 79
    • 33749545516 scopus 로고    scopus 로고
    • Rapid progression of Myelodysplastic syndrome to acute myeloid leukemia on sequential azathioprine, IFN-beta and copolymer-1 in a patient with multiple sclerosis
    • Then Bergh F, Niklas A, Strauss A, von Ahsen N, Niederwieser D, Schwarz J, et al. Rapid progression of Myelodysplastic syndrome to acute myeloid leukemia on sequential azathioprine, IFN-beta and copolymer-1 in a patient with multiple sclerosis. Acta Haematol. 2006;116(3):207-10.
    • (2006) Acta Haematol. , vol.116 , Issue.3 , pp. 207-210
    • Then Bergh, F.1    Niklas, A.2    Strauss, A.3    von Ahsen, N.4    Niederwieser, D.5    Schwarz, J.6
  • 80
    • 0031885653 scopus 로고    scopus 로고
    • Acute promyelocytic leukemia following mitoxantrone as single agent for the treatment of multiple sclerosis
    • Vicari AM, Ciceri F, Folli F, Lanzi R, Colombo B, Comi G, et al. Acute promyelocytic leukemia following mitoxantrone as single agent for the treatment of multiple sclerosis. Leukemia. 1998;12(3):441-2.
    • (1998) Leukemia. , vol.12 , Issue.3 , pp. 441-442
    • Vicari, A.M.1    Ciceri, F.2    Folli, F.3    Lanzi, R.4    Colombo, B.5    Comi, G.6
  • 81
    • 0037355117 scopus 로고    scopus 로고
    • Therapy-related acute myelogenous leukaemia (t-AML) in a patient with multiple sclerosis treated with mitoxantrone
    • Heesen C, Bruegmann M, Gbdamosi J, Koch E, Monch A, Buhmann C. Therapy-related acute myelogenous leukaemia (t-AML) in a patient with multiple sclerosis treated with mitoxantrone. Mult Scler. 2003;9(2):213-4.
    • (2003) Mult Scler. , vol.9 , Issue.2 , pp. 213-214
    • Heesen, C.1    Bruegmann, M.2    Gbdamosi, J.3    Koch, E.4    Monch, A.5    Buhmann, C.6
  • 83
    • 4444233652 scopus 로고    scopus 로고
    • Acute promyelocytic leukemia in a patient with multiple sclerosis following treatment with mitoxantrone
    • Novoselac AV, Reddy S, Sanmugarajah J. Acute promyelocytic leukemia in a patient with multiple sclerosis following treatment with mitoxantrone. Leukemia. 2004;18 (9):1561-2.
    • (2004) Leukemia. , vol.18 , Issue.9 , pp. 1561-1562
    • Novoselac, A.V.1    Reddy, S.2    Sanmugarajah, J.3
  • 84
    • 0347337764 scopus 로고    scopus 로고
    • Therapy related acute myeloblastic leukaemia after mitoxantrone treatment in a patient with multiple sclerosis
    • Delisse B, de Seze J, Mackowiak A, N'Kendjuo JB, Verier A, Derepeer O, et al. Therapy related acute myeloblastic leukaemia after mitoxantrone treatment in a patient with multiple sclerosis. Mult Scler. 2004;10(1):92.
    • (2004) Mult Scler. , vol.10 , Issue.1 , pp. 92
    • Delisse, B.1    de Seze, J.2    Mackowiak, A.3    N'Kendjuo, J.B.4    Verier, A.5    Derepeer, O.6
  • 85
    • 34250667954 scopus 로고    scopus 로고
    • Clinical follow-up of 304 patients with multiple sclerosis three years after mitoxantrone treatment
    • Debouverie M, Taillandier L, Pittion-Vouyovitch S, Louis S, Vespignani H. Clinical follow-up of 304 patients with multiple sclerosis three years after mitoxantrone treatment. Mult Scler. 2007;13(5):626-31.
    • (2007) Mult Scler. , vol.13 , Issue.5 , pp. 626-631
    • Debouverie, M.1    Taillandier, L.2    Pittion-Vouyovitch, S.3    Louis, S.4    Vespignani, H.5
  • 86
    • 3042535824 scopus 로고    scopus 로고
    • Acute myeloid leukaemia induced by mitoxantrone in a multiple sclerosis patient
    • Tanasescu R, Debouverie M, Pittion S, Anxionnat R, Vespignani H. Acute myeloid leukaemia induced by mitoxantrone in a multiple sclerosis patient. J Neurol. 2004; 251(6):762-3.
    • (2004) J Neurol. , vol.251 , Issue.6 , pp. 762-763
    • Tanasescu, R.1    Debouverie, M.2    Pittion, S.3    Anxionnat, R.4    Vespignani, H.5
  • 87
    • 4344569251 scopus 로고    scopus 로고
    • Mitoxantrone therapy in multiple sclerosis and acute leukaemia: A case report out of 644 treated patients
    • Voltz R, Starck M, Zingler V, Strupp M, Kolb HJ. Mitoxantrone therapy in multiple sclerosis and acute leukaemia: a case report out of 644 treated patients. Mult Scler. 2004;10(4): 472-4.
    • (2004) Mult Scler. , vol.10 , Issue.4 , pp. 472-474
    • Voltz, R.1    Starck, M.2    Zingler, V.3    Strupp, M.4    Kolb, H.J.5
  • 89
    • 33749432012 scopus 로고    scopus 로고
    • Sequential maintenance treatment with glatiramer acetate after mitoxantrone is safe and can limit exposure to immunosuppression in very active, relapsing remitting multiple sclerosis
    • Ramtahal J, Jacob A, Das K, Boggild M. Sequential maintenance treatment with glatiramer acetate after mitoxantrone is safe and can limit exposure to immunosuppression in very active, relapsing remitting multiple sclerosis. J Neurol. 2006;253(9):1160-4.
    • (2006) J Neurol. , vol.253 , Issue.9 , pp. 1160-1164
    • Ramtahal, J.1    Jacob, A.2    Das, K.3    Boggild, M.4
  • 90
    • 33751254778 scopus 로고    scopus 로고
    • Two new cases of acute promyelocytic leukemia following mitoxantrone treatment in patients with multiple sclerosis
    • Ledda A, Caocci G, Spinicci G, Cocco E, Mamusa E, La Nasa G. Two new cases of acute promyelocytic leukemia following mitoxantrone treatment in patients with multiple sclerosis. Leukemia. 2006;20(12): 2217-8.
    • (2006) Leukemia. , vol.20 , Issue.12 , pp. 2217-2218
    • Ledda, A.1    Caocci, G.2    Spinicci, G.3    Cocco, E.4    Mamusa, E.5    la Nasa, G.6
  • 91
    • 33645563825 scopus 로고    scopus 로고
    • Mitoxantrone as induction therapy in aggressive relapsing remitting multiple sclerosis: A descriptive analysis of 100 consecutive patients
    • Le Page E, Leray E, Taurin G, Coustans M, Chaperon J, Edan G. [Mitoxantrone as induction therapy in aggressive relapsing remitting multiple sclerosis: a descriptive analysis of 100 consecutive patients]. Rev Neurol (Paris). 2006;162(2):185-94.
    • (2006) Rev Neurol (Paris). , vol.162 , Issue.2 , pp. 185-194
    • le Page, E.1    Leray, E.2    Taurin, G.3    Coustans, M.4    Chaperon, J.5    Edan, G.6
  • 92
    • 43149122122 scopus 로고    scopus 로고
    • Analysis of incidence, risk factors and prognosis of acute promyelocytic leukaemia related to mitoxantrone therapy in multiple sclerosis
    • Cordioli C, Cattaneo C, Capra R. Analysis of incidence, risk factors and prognosis of acute promyelocytic leukaemia related to mitoxantrone therapy in multiple sclerosis. Neurology 2007;68(Suppl 1):A276.
    • (2007) Neurology , vol.68 , Issue.SUPPL. 1
    • Cordioli, C.1    Cattaneo, C.2    Capra, R.3
  • 94
    • 70450176057 scopus 로고    scopus 로고
    • Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required
    • Pascual AM, Tellez N, Bosca I, Mallada J, Belenguer A, Abellan I, et al. Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required. Mult Scler. 2009;15(11):1303-10.
    • (2009) Mult Scler. , vol.15 , Issue.11 , pp. 1303-1310
    • Pascual, A.M.1    Tellez, N.2    Bosca, I.3    Mallada, J.4    Belenguer, A.5    Abellan, I.6
  • 96
    • 77951786239 scopus 로고    scopus 로고
    • A clinical retrospective report on mitoxantrone treatment in active multiple sclerosis patients
    • Hum S, Lapierre Y. A clinical retrospective report on mitoxantrone treatment in active multiple sclerosis patients. Neurology 2009; 72(Suppl 3):A237.
    • (2009) Neurology , vol.72 , Issue.SUPPL. 3
    • Hum, S.1    Lapierre, Y.2
  • 97
    • 0036783808 scopus 로고    scopus 로고
    • A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis
    • Ghalie RG, Mauch E, Edan G, Hartung HP, Gonsette RE, Eisenmann S, et al. A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis. Mult Scler. 2002;8(5):441-5.
    • (2002) Mult Scler. , vol.8 , Issue.5 , pp. 441-445
    • Ghalie, R.G.1    Mauch, E.2    Edan, G.3    Hartung, H.P.4    Gonsette, R.E.5    Eisenmann, S.6
  • 98
  • 99
    • 74049140477 scopus 로고    scopus 로고
    • Mitoxantrone: Benefits and risks in multiple sclerosis patients
    • Martinelli V, Radaelli M, Straffi L, Rodegher M, Comi G. Mitoxantrone: benefits and risks in multiple sclerosis patients. Neurol Sci. 2009;30 (Suppl 2):S167-70.
    • (2009) Neurol Sci. , vol.30 , Issue.SUPPL. 2
    • Martinelli, V.1    Radaelli, M.2    Straffi, L.3    Rodegher, M.4    Comi, G.5
  • 100
    • 0034034163 scopus 로고    scopus 로고
    • The incidence of acute promyelocytic leukemia appears constant over most of a human lifespan, implying only one rate limiting mutation
    • Vickers M, Jackson G, Taylor P. The incidence of acute promyelocytic leukemia appears constant over most of a human lifespan, implying only one rate limiting mutation. Leukemia. 2000;14(4):722-6.
    • (2000) Leukemia. , vol.14 , Issue.4 , pp. 722-726
    • Vickers, M.1    Jackson, G.2    Taylor, P.3
  • 101
    • 77951828930 scopus 로고    scopus 로고
    • Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
    • Marriott JJ, Miyasaki JM, Gronseth G, O'Connor PW. Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 74(18):1463-70.
    • Neurology , vol.74 , Issue.18 , pp. 1463-1470
    • Marriott, J.J.1    Miyasaki, J.M.2    Gronseth, G.3    O'Connor, P.W.4
  • 102
    • 63449128972 scopus 로고    scopus 로고
    • Therapy-related acute leukaemia with Mitoxantrone: What is the risk and can we minimise it
    • Ellis R, Boggild M. Therapy-related acute leukaemia with Mitoxantrone: what is the risk and can we minimise it? Mult Scler. 2009;15(4):505-8.
    • (2009) Mult Scler. , vol.15 , Issue.4 , pp. 505-508
    • Ellis, R.1    Boggild, M.2
  • 103
    • 79953888314 scopus 로고    scopus 로고
    • Presenting features and treatment outcome of acute promyelocytic leukemia arising after multiple sclerosis
    • Ammatuna E, Montesinos P, Hasan SK, Ramadan SM, Esteve J, Hubmann M, et al. Presenting features and treatment outcome of acute promyelocytic leukemia arising after multiple sclerosis. Haematologica. 96(4):621-5.
    • Haematologica , vol.96 , Issue.4 , pp. 621-625
    • Ammatuna, E.1    Montesinos, P.2    Hasan, S.K.3    Ramadan, S.M.4    Esteve, J.5    Hubmann, M.6
  • 104
    • 0037105375 scopus 로고    scopus 로고
    • Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: The GIMEMA experience
    • Pulsoni A, Pagano L, Lo Coco F, Avvisati G, Mele L, Di Bona E, et al. Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience. Blood. 2002;100 (6):1972-6.
    • (2002) Blood. , vol.100 , Issue.6 , pp. 1972-1976
    • Pulsoni, A.1    Pagano, L.2    Lo Coco, F.3    Avvisati, G.4    Mele, L.5    Di Bona, E.6
  • 105
    • 38149138096 scopus 로고    scopus 로고
    • Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I
    • Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008;58(1): 15-25.
    • (2008) Arthritis Rheum. , vol.58 , Issue.1 , pp. 15-25
    • Helmick, C.G.1    Felson, D.T.2    Lawrence, R.C.3    Gabriel, S.4    Hirsch, R.5    Kwoh, C.K.6
  • 106
    • 44849116038 scopus 로고    scopus 로고
    • Clinical trials in systemic lupus erythematosus (SLE): Lessons from the past as we proceed to the future--the EULAR recommendations for the management of SLE and the use of endpoints in clinical trials
    • Bertsias G, Gordon C, Boumpas DT. Clinical trials in systemic lupus erythematosus (SLE): lessons from the past as we proceed to the future--the EULAR recommendations for the management of SLE and the use of endpoints in clinical trials. Lupus. 2008;17(5): 437-42.
    • (2008) Lupus. , vol.17 , Issue.5 , pp. 437-442
    • Bertsias, G.1    Gordon, C.2    Boumpas, D.T.3
  • 107
    • 0014127904 scopus 로고
    • Systemic lupus erythematosus and acute myeloblastic leukemia. Report of their coexistence and a survey of possible associating features
    • Deaton JG, Levin WC. Systemic lupus erythematosus and acute myeloblastic leukemia. Report of their coexistence and a survey of possible associating features. Arch Intern Med. 1967;120(3):345-8.
    • (1967) Arch Intern Med. , vol.120 , Issue.3 , pp. 345-348
    • Deaton, J.G.1    Levin, W.C.2
  • 108
    • 0016284086 scopus 로고
    • Multiple myeloma terminating in acute leukemia. Report of 12 cases and review of the literature
    • Rosner F, Grunwald H. Multiple myeloma terminating in acute leukemia. Report of 12 cases and review of the literature. Am J Med. 1974;57(6):927-39.
    • (1974) Am J Med. , vol.57 , Issue.6 , pp. 927-939
    • Rosner, F.1    Grunwald, H.2
  • 110
    • 0019507259 scopus 로고
    • A case of systemic lupus erythematosus with sideroblastic anaemia terminating in erythroleukaemia
    • Ng HS, Ng HW, Sinniah R, Feng PH. A case of systemic lupus erythematosus with sideroblastic anaemia terminating in erythroleukaemia. Ann Rheum Dis. 1981;40(4): 422-6.
    • (1981) Ann Rheum Dis. , vol.40 , Issue.4 , pp. 422-426
    • Ng, H.S.1    Ng, H.W.2    Sinniah, R.3    Feng, P.H.4
  • 111
    • 0020429744 scopus 로고
    • Preleukemic syndrome simulating SLE. A case report
    • Saxne T, Turesson I, Wollheim FA. Preleukemic syndrome simulating SLE. A case report. Acta Med Scand. 1982;212(6): 421-4.
    • (1982) Acta Med Scand. , vol.212 , Issue.6 , pp. 421-424
    • Saxne, T.1    Turesson, I.2    Wollheim, F.A.3
  • 112
    • 0021396150 scopus 로고
    • Acute myeloid leukemia with preceding systemic lupus erythematosus and autoimmune hemolytic anemia
    • Tsunematsu Y, Koide R, Sasaki M, Takahashi H. Acute myeloid leukemia with preceding systemic lupus erythematosus and autoimmune hemolytic anemia. Jpn J Clin Oncol. 1984;14(1):107-13.
    • (1984) Jpn J Clin Oncol. , vol.14 , Issue.1 , pp. 107-113
    • Tsunematsu, Y.1    Koide, R.2    Sasaki, M.3    Takahashi, H.4
  • 113
    • 0022091116 scopus 로고
    • Acute granulocytic leukemia following systemic lupus erythematosus
    • Paolozzi FP, Goldberg J. Acute granulocytic leukemia following systemic lupus erythematosus. Am J Med Sci. 1985;290(1):32-5.
    • (1985) Am J Med Sci. , vol.290 , Issue.1 , pp. 32-35
    • Paolozzi, F.P.1    Goldberg, J.2
  • 114
    • 0024245628 scopus 로고
    • Acute nonlymphocytic leukemia following short-term, intermittent, intravenous cyclophosphamide treatment of lupus nephritis
    • Gibbons RB, Westerman E. Acute nonlymphocytic leukemia following short-term, intermittent, intravenous cyclophosphamide treatment of lupus nephritis. Arthritis Rheum. 1988;31(12):1552-4.
    • (1988) Arthritis Rheum. , vol.31 , Issue.12 , pp. 1552-1554
    • Gibbons, R.B.1    Westerman, E.2
  • 115
    • 0025580669 scopus 로고
    • Acute promyelocytic leukemia developed in the course of systemic lupus erythematosus: A case report
    • Taguchi F, Miyoshi T, Nakajima N, Nishimura J, Nawata H. [Acute promyelocytic leukemia developed in the course of systemic lupus erythematosus: a case report]. Rinsho Ketsueki. 1990;31(12):1965-6.
    • (1990) Rinsho Ketsueki. , vol.31 , Issue.12 , pp. 1965-1966
    • Taguchi, F.1    Miyoshi, T.2    Nakajima, N.3    Nishimura, J.4    Nawata, H.5
  • 116
    • 0026473159 scopus 로고
    • Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents
    • Vasquez S, Kavanaugh AF, Schneider NR, Wacholtz MC, Lipsky PE. Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents. J Rheumatol. 1992;19 (10):1625-7.
    • (1992) J Rheumatol. , vol.19 , Issue.10 , pp. 1625-1627
    • Vasquez, S.1    Kavanaugh, A.F.2    Schneider, N.R.3    Wacholtz, M.C.4    Lipsky, P.E.5
  • 117
    • 0030844711 scopus 로고    scopus 로고
    • Acute megakaryoblastic leukaemia in a patient with systemic lupus erythematosus
    • Colovic M, Jankovic G, Lazarevic V, Novak A. Acute megakaryoblastic leukaemia in a patient with systemic lupus erythematosus. Med Oncol. 1997;14(1):31-4.
    • (1997) Med Oncol. , vol.14 , Issue.1 , pp. 31-34
    • Colovic, M.1    Jankovic, G.2    Lazarevic, V.3    Novak, A.4
  • 118
    • 0030979803 scopus 로고    scopus 로고
    • Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: Regression of both diseases after autologous bone marrow transplantation
    • Meloni G, Capria S, Vignetti M, Mandelli F, Modena V. Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation. Blood. 1997;89(12):4659.
    • (1997) Blood. , vol.89 , Issue.12 , pp. 4659
    • Meloni, G.1    Capria, S.2    Vignetti, M.3    Mandelli, F.4    Modena, V.5
  • 119
    • 37349118282 scopus 로고    scopus 로고
    • Erythroleukaemia complicating ANA-negative systemic lupus erythematosus
    • Eilertsen GO, Nossent JC. Erythroleukaemia complicating ANA-negative systemic lupus erythematosus. Scand J Rheumatol. 2007; 36(6):478-80.
    • (2007) Scand J Rheumatol. , vol.36 , Issue.6 , pp. 478-480
    • Eilertsen, G.O.1    Nossent, J.C.2
  • 121
    • 19544378505 scopus 로고    scopus 로고
    • Exploring the links between systemic lupus erythematosus and cancer
    • Bernatsky S, Ramsey-Goldman R, Clarke A. Exploring the links between systemic lupus erythematosus and cancer. Rheum Dis Clin North Am. 2005;31(2):387-402, viii-ix.
    • (2005) Rheum Dis Clin North Am. , vol.31 , Issue.2
    • Bernatsky, S.1    Ramsey-Goldman, R.2    Clarke, A.3
  • 122
    • 34948884016 scopus 로고    scopus 로고
    • Occurrence of malignancies in Hungarian patients with systemic lupus erythematosus: Results from a single center
    • Tarr T, Gyorfy B, Szekanecz E, Bhattoa HP, Zeher M, Szegedi G, et al. Occurrence of malignancies in Hungarian patients with systemic lupus erythematosus: results from a single center. Ann NY Acad Sci. 2007; 1108:76-82.
    • (2007) Ann NY Acad Sci. , vol.1108 , pp. 76-82
    • Tarr, T.1    Gyorfy, B.2    Szekanecz, E.3    Bhattoa, H.P.4    Zeher, M.5    Szegedi, G.6
  • 123
    • 0036247498 scopus 로고    scopus 로고
    • Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades
    • Moss KE, Ioannou Y, Sultan SM, Haq I, Isenberg DA. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis. 2002;61(5):409-13.
    • (2002) Ann Rheum Dis. , vol.61 , Issue.5 , pp. 409-413
    • Moss, K.E.1    Ioannou, Y.2    Sultan, S.M.3    Haq, I.4    Isenberg, D.A.5
  • 124
    • 33845976381 scopus 로고    scopus 로고
    • Mortality related to cerebrovascular disease in systemic lupus erythematosus
    • Bernatsky S, Clarke A, Gladman DD, Urowitz M, Fortin PR, Barr SG, et al. Mortality related to cerebrovascular disease in systemic lupus erythematosus. Lupus. 2006;15(12):835-9.
    • (2006) Lupus. , vol.15 , Issue.12 , pp. 835-839
    • Bernatsky, S.1    Clarke, A.2    Gladman, D.D.3    Urowitz, M.4    Fortin, P.R.5    Barr, S.G.6
  • 125
    • 33846176558 scopus 로고    scopus 로고
    • Scleroderma and chronic myeloid leukemia: A sheer coincidence, a consequence of long lasting D-penicillamine therapy or a plausible relationship of both diseases
    • Kasifoglu T, Korkmaz C, Yasar S, Gulbas Z. Scleroderma and chronic myeloid leukemia: a sheer coincidence, a consequence of long lasting D-penicillamine therapy or a plausible relationship of both diseases? Rheumatol Int. 2006;27(2):175-7.
    • (2006) Rheumatol Int. , vol.27 , Issue.2 , pp. 175-177
    • Kasifoglu, T.1    Korkmaz, C.2    Yasar, S.3    Gulbas, Z.4
  • 126
    • 33745059043 scopus 로고    scopus 로고
    • Rheumatic diseases and chronic myelogenous leukemia, presentation of four cases and review of the literature
    • Senel S, Kaya E, Aydogdu I, Erkurt MA, Kuku I. Rheumatic diseases and chronic myelogenous leukemia, presentation of four cases and review of the literature. Rheumatol Int. 2006;26(9):857-61.
    • (2006) Rheumatol Int. , vol.26 , Issue.9 , pp. 857-861
    • Senel, S.1    Kaya, E.2    Aydogdu, I.3    Erkurt, M.A.4    Kuku, I.5
  • 127
    • 0028504360 scopus 로고
    • Concordant improvement of progressive systemic sclerosis and chronic myelogenous leukemia with interferon-alpha treatment
    • Watanabe S, Sugihara T, Takahashi M, Ata K, Kanzaki A, Yamada O, et al. [Concordant improvement of progressive systemic sclerosis and chronic myelogenous leukemia with interferon-alpha treatment]. Rinsho Ketsueki. 1994;35(9):895-7.
    • (1994) Rinsho Ketsueki. , vol.35 , Issue.9 , pp. 895-897
    • Watanabe, S.1    Sugihara, T.2    Takahashi, M.3    Ata, K.4    Kanzaki, A.5    Yamada, O.6
  • 128
    • 0025605931 scopus 로고
    • Systemic sclerosis and chronic lymphocytic leukaemia
    • Sidi Y, Fadilah R, Pinkhas J, Prokocimer M. Systemic sclerosis and chronic lymphocytic leukaemia. Postgrad Med J. 1990;66(782): 1071-2.
    • (1990) Postgrad Med J. , vol.66 , Issue.782 , pp. 1071-1072
    • Sidi, Y.1    Fadilah, R.2    Pinkhas, J.3    Prokocimer, M.4
  • 129
    • 0025859432 scopus 로고
    • Chronic lymphoid leukemia in a case of systemic scleroderma
    • Angeli C, Lacour JP, Taillan B, Ortonne JP. [Chronic lymphoid leukemia in a case of systemic scleroderma]. Presse Med. 1991;20 (9):426.
    • (1991) Presse Med. , vol.20 , Issue.9 , pp. 426
    • Angeli, C.1    Lacour, J.P.2    Taillan, B.3    Ortonne, J.P.4
  • 134
    • 0024588821 scopus 로고
    • Atypical scleroderma associated with multiple myeloma
    • Nakanishi H, Takehara K, Soma Y, Ishibashi Y. Atypical scleroderma associated with multiple myeloma. Dermatologica. 1989; 178(3):176-8.
    • (1989) Dermatologica. , vol.178 , Issue.3 , pp. 176-178
    • Nakanishi, H.1    Takehara, K.2    Soma, Y.3    Ishibashi, Y.4
  • 135
    • 33645009877 scopus 로고    scopus 로고
    • Solitary extramedullary plasmacytoma and granulomatous sialadenitis of the parotid gland preceding a B-cell non-Hodgkin's lymphoma
    • Gouveris H, Hansen T, Franke K. Solitary extramedullary plasmacytoma and granulomatous sialadenitis of the parotid gland preceding a B-cell non-Hodgkin's lymphoma. Mund Kiefer Gesichtschir. 2006;10(2):122-5.
    • (2006) Mund Kiefer Gesichtschir. , vol.10 , Issue.2 , pp. 122-125
    • Gouveris, H.1    Hansen, T.2    Franke, K.3
  • 136
    • 0026009468 scopus 로고
    • Non-Hodgkin's lymphoma associated with scleroderma
    • Pulik M, Teillet-Thiebaud F, Mahe A, Teillet F. [Non-Hodgkin's lymphoma associated with scleroderma]. Presse Med. 1991;20(31): 1513-4.
    • (1991) Presse Med. , vol.20 , Issue.31 , pp. 1513-1514
    • Pulik, M.1    Teillet-Thiebaud, F.2    Mahe, A.3    Teillet, F.4
  • 138
    • 48449085252 scopus 로고    scopus 로고
    • Incidence of lymphoma in systemic sclerosis: A retrospective analysis of 218 Hungarian patients with systemic sclerosis
    • Szekanecz E, Szamosi S, Gergely L, Keszthelyi P, Szekanecz Z, Szucs G. Incidence of lymphoma in systemic sclerosis: a retrospective analysis of 218 Hungarian patients with systemic sclerosis. Clin Rheumatol. 2008;27(9):1163-6.
    • (2008) Clin Rheumatol. , vol.27 , Issue.9 , pp. 1163-1166
    • Szekanecz, E.1    Szamosi, S.2    Gergely, L.3    Keszthelyi, P.4    Szekanecz, Z.5    Szucs, G.6
  • 139
    • 0017846545 scopus 로고
    • Association of systemic scleroderma with lymphocytic leukemia
    • Golovanova OE, Pechorina EG. [Association of systemic scleroderma with lymphocytic leukemia]. Ter Arkh. 1978;50(6):131-4.
    • (1978) Ter Arkh. , vol.50 , Issue.6 , pp. 131-134
    • Golovanova, O.E.1    Pechorina, E.G.2
  • 140
    • 76549235689 scopus 로고
    • Scleroderma associated with malignant estrapenic leukoblastosis ("leukemia"); case report illustrating therapeutic response to orally administered crude "B" fermentation concentrates
    • Barnard RD, Appel A. Scleroderma associated with malignant estrapenic leukoblastosis ("leukemia"); case report illustrating therapeutic response to orally administered crude "B" fermentation concentrates. Urol Cutaneous Rev. 1950;54(6):345-8.
    • (1950) Urol Cutaneous Rev. , vol.54 , Issue.6 , pp. 345-348
    • Barnard, R.D.1    Appel, A.2
  • 141
  • 142
    • 0019961648 scopus 로고
    • Acute lymphoblastic leukemia in a patient receiving penicillamine for Wilson's disease
    • Gilman PA, Holtzman NA. Acute lymphoblastic leukemia in a patient receiving penicillamine for Wilson's disease. JAMA. 1982;248(4):467-8.
    • (1982) JAMA. , vol.248 , Issue.4 , pp. 467-468
    • Gilman, P.A.1    Holtzman, N.A.2
  • 143
    • 0017809875 scopus 로고
    • Chronic lymphocytic leukaemia after treatment with penicillamine
    • Clausen JE, Arndal JC, Gram L, Kudahl SB. Chronic lymphocytic leukaemia after treatment with penicillamine. Lancet. 1978;2 (8081):152.
    • (1978) Lancet. , vol.2 , Issue.8081 , pp. 152
    • Clausen, J.E.1    Arndal, J.C.2    Gram, L.3    Kudahl, S.B.4
  • 144
    • 0034657370 scopus 로고    scopus 로고
    • Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer
    • Ramenghi U, Bonissoni S, Migliaretti G, DeFranco S, Bottarel F, Gambaruto C, et al. Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer. Blood. 2000;95 (10):3176-82.
    • (2000) Blood. , vol.95 , Issue.10 , pp. 3176-3182
    • Ramenghi, U.1    Bonissoni, S.2    Migliaretti, G.3    de Franco, S.4    Bottarel, F.5    Gambaruto, C.6
  • 145
    • 79957643482 scopus 로고    scopus 로고
    • The new era of autoimmune disease research
    • Koike T. The new era of autoimmune disease research. Arthritis Res Ther. 2011; 13(3):113.
    • (2011) Arthritis Res Ther. , vol.13 , Issue.3 , pp. 113
    • Koike, T.1
  • 146
    • 0036022402 scopus 로고    scopus 로고
    • Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: An update
    • Soldani C, Scovassi AI. Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update. Apoptosis. 2002;7(4):321-8.
    • (2002) Apoptosis. , vol.7 , Issue.4 , pp. 321-328
    • Soldani, C.1    Scovassi, A.I.2
  • 147
    • 0034995205 scopus 로고    scopus 로고
    • Mutations in apoptosis genes: A pathogenetic factor for human disease
    • Mullauer L, Gruber P, Sebinger D, Buch J, Wohlfart S, Chott A. Mutations in apoptosis genes: a pathogenetic factor for human disease. Mutat Res. 2001;488(3):211-31.
    • (2001) Mutat Res. , vol.488 , Issue.3 , pp. 211-231
    • Mullauer, L.1    Gruber, P.2    Sebinger, D.3    Buch, J.4    Wohlfart, S.5    Chott, A.6
  • 148
    • 38549139638 scopus 로고    scopus 로고
    • Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndrome
    • Cerutti E, Campagnoli MF, Ferretti M, Garelli E, Crescenzio N, Rosolen A, et al. Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndrome. BMC Immunol. 2007;8:28.
    • (2007) BMC Immunol. , vol.8 , pp. 28
    • Cerutti, E.1    Campagnoli, M.F.2    Ferretti, M.3    Garelli, E.4    Crescenzio, N.5    Rosolen, A.6
  • 149
    • 59649094980 scopus 로고    scopus 로고
    • A possible role of Fas-ligand-mediated "reverse signaling" in pathogenesis of rheumatoid arthritis and systemic lupus erythematosus
    • Telegina E, Reshetnyak T, Moshnikova A, Proussakova O, Zhukova A, Kuznetsova A, et al. A possible role of Fas-ligand-mediated "reverse signaling" in pathogenesis of rheumatoid arthritis and systemic lupus erythematosus. Immunol Lett. 2009;122(1):12-7.
    • (2009) Immunol Lett. , vol.122 , Issue.1 , pp. 12-17
    • Telegina, E.1    Reshetnyak, T.2    Moshnikova, A.3    Proussakova, O.4    Zhukova, A.5    Kuznetsova, A.6
  • 150
    • 34548642127 scopus 로고    scopus 로고
    • Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: From bench to bedside
    • Martelli AM, Tazzari PL, Evangelisti C, Chiarini F, Blalock WL, Billi AM, et al. Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside. Curr Med Chem. 2007;14(19):2009-23.
    • (2007) Curr Med Chem. , vol.14 , Issue.19 , pp. 2009-2023
    • Martelli, A.M.1    Tazzari, P.L.2    Evangelisti, C.3    Chiarini, F.4    Blalock, W.L.5    Billi, A.M.6
  • 152
    • 11244331548 scopus 로고    scopus 로고
    • PI3K/AKT signaling and systemic autoimmunity
    • Patel RK, Mohan C. PI3K/AKT signaling and systemic autoimmunity. Immunol Res. 2005;31(1):47-55.
    • (2005) Immunol Res. , vol.31 , Issue.1 , pp. 47-55
    • Patel, R.K.1    Mohan, C.2
  • 154
    • 80052043181 scopus 로고    scopus 로고
    • Inhibition of inflammatory mediators and related signaling pathways by macrophage-stimulating protein in rheumatoid arthritis synovial fibroblasts
    • Tong XM, Wang JC, Shen Y, Xie JJ, Zhang JY, Jin J. Inhibition of inflammatory mediators and related signaling pathways by macrophage-stimulating protein in rheumatoid arthritis synovial fibroblasts. Inflamm Res. 2011;60(9):823-9.
    • (2011) Inflamm Res. , vol.60 , Issue.9 , pp. 823-829
    • Tong, X.M.1    Wang, J.C.2    Shen, Y.3    Xie, J.J.4    Zhang, J.Y.5    Jin, J.6
  • 156
    • 67650303113 scopus 로고    scopus 로고
    • The AKT axis as a therapeutic target in autoimmune diseases
    • Wu T, Mohan C. The AKT axis as a therapeutic target in autoimmune diseases. Endocr Metab Immune Disord Drug Targets. 2009;9(2):145-50.
    • (2009) Endocr Metab Immune Disord Drug Targets. , vol.9 , Issue.2 , pp. 145-150
    • Wu, T.1    Mohan, C.2
  • 157
    • 83755166163 scopus 로고    scopus 로고
    • Physiological roles of mitogenactivated-protein-kinase-activated p38-regulated/ activated protein kinase
    • Kostenko S, Dumitriu G, Laegreid KJ, Moens U. Physiological roles of mitogenactivated-protein-kinase-activated p38-regulated/ activated protein kinase. World J Biol Chem. 2011;2(5):73-89.
    • (2011) World J Biol Chem. , vol.2 , Issue.5 , pp. 73-89
    • Kostenko, S.1    Dumitriu, G.2    Laegreid, K.J.3    Moens, U.4
  • 158
    • 69449088578 scopus 로고    scopus 로고
    • MAPK signaling pathways in the regulation of hematopoiesis
    • Geest CR, Coffer PJ. MAPK signaling pathways in the regulation of hematopoiesis. J Leukoc Biol. 2009;86(2):237-50.
    • (2009) J Leukoc Biol. , vol.86 , Issue.2 , pp. 237-250
    • Geest, C.R.1    Coffer, P.J.2
  • 159
    • 68249131563 scopus 로고    scopus 로고
    • Molecular signaling blockade as a new approach to inhibit leukocyte-endothelial interactions for inflammatory bowel disease treatment
    • Scaldaferri F, Correale C, Gasbarrini A, Danese S. Molecular signaling blockade as a new approach to inhibit leukocyte-endothelial interactions for inflammatory bowel disease treatment. Cell Adh Migr. 2009;3(3): 296-9.
    • (2009) Cell Adh Migr. , vol.3 , Issue.3 , pp. 296-299
    • Scaldaferri, F.1    Correale, C.2    Gasbarrini, A.3    Danese, S.4
  • 160
    • 77953177649 scopus 로고    scopus 로고
    • Cancer immunoediting from immunosurveillance to tumor escape in microvillus-formed niche: A study of syngeneic orthotopic rat bladder cancer model in comparison with human bladder cancer
    • Arum CJ, Anderssen E, Viset T, Kodama Y, Lundgren S, Chen D, et al. Cancer immunoediting from immunosurveillance to tumor escape in microvillus-formed niche: a study of syngeneic orthotopic rat bladder cancer model in comparison with human bladder cancer. Neoplasia. 2010;12(6):434-42.
    • (2010) Neoplasia. , vol.12 , Issue.6 , pp. 434-442
    • Arum, C.J.1    Anderssen, E.2    Viset, T.3    Kodama, Y.4    Lundgren, S.5    Chen, D.6
  • 161
    • 34047220868 scopus 로고    scopus 로고
    • Cancer immunoediting from immune surveillance to immune escape
    • Kim R, Emi M, Tanabe K. Cancer immunoediting from immune surveillance to immune escape. Immunology. 2007;121 (1):1-14.
    • (2007) Immunology. , vol.121 , Issue.1 , pp. 1-14
    • Kim, R.1    Emi, M.2    Tanabe, K.3
  • 162
    • 47849098044 scopus 로고    scopus 로고
    • Inflammation: Gearing the journey to cancer
    • Kundu JK, Surh YJ. Inflammation: gearing the journey to cancer. Mutat Res. 2008;659 (1-2):15-30.
    • (2008) Mutat Res. , vol.659 , Issue.1-2 , pp. 15-30
    • Kundu, J.K.1    Surh, Y.J.2
  • 163
    • 68449097467 scopus 로고    scopus 로고
    • Towards understanding the role of cancer-associated inflammation in chemoresistance
    • de Visser KE, Jonkers J. Towards understanding the role of cancer-associated inflammation in chemoresistance. Curr Pharm Des. 2009;15(16):1844-53.
    • (2009) Curr Pharm Des. , vol.15 , Issue.16 , pp. 1844-1853
    • de Visser, K.E.1    Jonkers, J.2
  • 164
    • 33750467991 scopus 로고    scopus 로고
    • Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models
    • Gerondakis S, Grumont R, Gugasyan R, Wong L, Isomura I, Ho W, et al. Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. Oncogene. 2006;25(51):6781-99.
    • (2006) Oncogene. , vol.25 , Issue.51 , pp. 6781-6799
    • Gerondakis, S.1    Grumont, R.2    Gugasyan, R.3    Wong, L.4    Isomura, I.5    Ho, W.6
  • 165
    • 0037180757 scopus 로고    scopus 로고
    • Inflammation and cancer
    • Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860-7.
    • (2002) Nature. , vol.420 , Issue.6917 , pp. 860-867
    • Coussens, L.M.1    Werb, Z.2
  • 166
    • 67849128689 scopus 로고    scopus 로고
    • Stronger inflammatory/cytotoxic T-cell response in women identified by microarray analysis
    • Hewagama A, Patel D, Yarlagadda S, Strickland FM, Richardson BC. Stronger inflammatory/cytotoxic T-cell response in women identified by microarray analysis. Genes Immun. 2009;10(5):509-16.
    • (2009) Genes Immun. , vol.10 , Issue.5 , pp. 509-516
    • Hewagama, A.1    Patel, D.2    Yarlagadda, S.3    Strickland, F.M.4    Richardson, B.C.5
  • 167
    • 0026596863 scopus 로고
    • The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated
    • Young NS. The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated. Blood. 1992;79(6):1385-92.
    • (1992) Blood. , vol.79 , Issue.6 , pp. 1385-1392
    • Young, N.S.1
  • 168
    • 0015071763 scopus 로고
    • Spontaneous reticulum cell sarcomas developing in C3H-HeJ mice on prolonged immunosuppressive therapy
    • Hattan D, Cerilli GJ. Spontaneous reticulum cell sarcomas developing in C3H-HeJ mice on prolonged immunosuppressive therapy. Transplantation. 1971;11(6):580-1.
    • (1971) Transplantation. , vol.11 , Issue.6 , pp. 580-581
    • Hattan, D.1    Cerilli, G.J.2
  • 169
    • 0016589060 scopus 로고
    • Accelerated induction of skin cancers by ultraviolet radiation in hairless mice treated with immunosuppressive agents
    • Koranda FC, Loeffler RT, Koranda DM, Penn I. Accelerated induction of skin cancers by ultraviolet radiation in hairless mice treated with immunosuppressive agents. Surg Forum. 1975;26:145-6.
    • (1975) Surg Forum. , vol.26 , pp. 145-146
    • Koranda, F.C.1    Loeffler, R.T.2    Koranda, D.M.3    Penn, I.4
  • 170
    • 0015036176 scopus 로고
    • Immunosuppression, virus and oncogenesis in mice
    • Nehlsen SL. Immunosuppression, virus and oncogenesis in mice. Transplant Proc. 1971;3 (1):811-3.
    • (1971) Transplant Proc. , vol.3 , Issue.1 , pp. 811-813
    • Nehlsen, S.L.1
  • 172
    • 77953522671 scopus 로고    scopus 로고
    • Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: Association of DNA breaks with specific DNA motifs at PML and RARA loci
    • Hasan SK, Ottone T, Schlenk RF, Xiao Y, Wiemels JL, Mitra ME, et al. Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: association of DNA breaks with specific DNA motifs at PML and RARA loci. Genes Chromosomes Cancer. 2010;49(8):726-32.
    • (2010) Genes Chromosomes Cancer. , vol.49 , Issue.8 , pp. 726-732
    • Hasan, S.K.1    Ottone, T.2    Schlenk, R.F.3    Xiao, Y.4    Wiemels, J.L.5    Mitra, M.E.6
  • 173
    • 36348967181 scopus 로고    scopus 로고
    • Therapy-related leukemia and myelodysplasia: Susceptibility and incidence
    • Leone G, Pagano L, Ben-Yehuda D, Voso MT. Therapy-related leukemia and myelodysplasia: susceptibility and incidence. Haematologica. 2007;92(10):1389-98.
    • (2007) Haematologica. , vol.92 , Issue.10 , pp. 1389-1398
    • Leone, G.1    Pagano, L.2    Ben-Yehuda, D.3    Voso, M.T.4
  • 176
    • 0027164953 scopus 로고
    • The association of malignancy with SLE: An analysis of 150 patients under long-term review
    • Menon S, Snaith ML, Isenberg DA. The association of malignancy with SLE: an analysis of 150 patients under long-term review. Lupus. 1993;2(3):177-81.
    • (1993) Lupus. , vol.2 , Issue.3 , pp. 177-181
    • Menon, S.1    Snaith, M.L.2    Isenberg, D.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.